The following image may be reproduced without modification using the attribution “Graph source – MD Becker Partners (www.mdbpartners.com).” Click on the image to enlarge.
Biotech Deal Activity a Mixed Bag During Major Conference
January 17, 2011 By Leave a Comment
Last week, thousands of registrants gathered in San Francisco, California for the JP Morgan Healthcare Conference [JPMHC] to hear 25-minute presentations from 364 life science companies. For industry executives and investors, deal activity emanating from the annual event typically serves as a good barometer for the rest of the year. Adding to an already hectic [...]
Biotech’s Top and Bottom Ten from 2010
January 5, 2011 By Leave a Comment
At the start of the year, we provided a favorable outlook for the biotechnology industry in 2010 that was based on the same six drivers we proposed for 2009, which included the following: Sector’s defensive characteristics and impact on future economic growth Highest number of annual new product approvals since 2004 Record number of products [...]
2010 Cancer Immunotherapy: A Long-Awaited Reality
October 28, 2010 By Leave a Comment
Selected photos from Cancer Immunotherapy: A Long-Awaited Reality conference hosted by MD Becker Partners and BioBusiness.TV held at the New York Academy of Medicine on October 21, 2010 (Note: Click on photo to enlarge). Alternatively, click here to view a video montage of the conference photos.
Cyclin-dependent Cancer Confab Preview
April 16, 2010 By Leave a Comment
For more than a century, the American Association of Cancer Research [AACR] has held its annual meeting and this weekend will kick off the 101st event in Washington, DC, which is being held April 17-21, 2010. Many pharmaceutical and biotechnology companies will be presenting new data and approximately 6,300 abstracts will be discussed in oral [...]
Follow MD Becker Partners